Synopsis
Highlights
History
Business
Property
Subsidiaries
Long term debt
Capital stock
Earnings estimates
Business segments
|
Business Summary
St. Jude Medical, together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Co.'s seven principal product categories are as follows: tachycardia implantable cardioverter defibrillator systems, atrial fibrillation products, pacemaker systems, vascular products, structural heart products, neuromodulation products, and thoratec products. The principal geographic markets for Co.'s products are the U.S., Europe and Japan.Pricing Summary
Time Period
No Chart Available
Yesterday | 5 Days | 30 Days | |
---|---|---|---|
Close | 80.82 | 80.82 | 80.82 |
Volume | N/A | N/A | N/A |
52 Week High/Low : | 83.90 - 49.46 | ||
% Price Change (100 Days) : | N/A | ||
200-Day Moving Avg. : | 79.88 |
Company News
There is no news found for this company
Corporate Events
Key Executives
Age | Salary | |
---|---|---|
Executive Chairman | 66 | 1,110,000 |
Age | Salary | |
President,Chief Executive Officer | 62 | 800,000 |
Age | Salary | |
Group President | 57 | 721,000 |
Age | Salary | |
Executive Vice President | 66 | 768,500 |
Age | ||
Vice President,Chief Marketing Officer,Division Officer | 44 | |
Key Financials
(In USD as of 10/01/2016)Income Statement | |
---|---|
Revenue | 5,956m |
Net Income | 658m |
EPS from Continuing Operations | 2.28 |
EPS - Net Income - Diluted | 2.28 |
Revenue per Share | 20.88 |
Balance Sheet | |
Total Assets | 12,541m |
Total Liabilities | 8,055m |
Shareholders' Equity | 4,486m |
Total Assets per Share | 43.91 |
Net Assets per Share | 15.71 |
Cash Flows | |
Cash from Operations | 1,092m |
Cash from Investing | -3,544m |
Cash from Financing | 321m |
Capital Expenditures | 251m |
Cash Flow per Share | 3.77 |